(Full bibliography includes over 100 publications, 6 patents, 1 edited book and 6 book chapters)
“Inhibition of DC-SIGN-mediated HIV-1 infection by complementary actions of dendritic cell receptor antagonists and env-targeting virus inactivators”
Pustylnikov S, Dave RS, Khan ZK, Porkolab V, Rashad AA, Hutchinson M, Fieschi F, Chaiken I, and P Jain
AIDS Research and Human Retroviruses, 31. Doi: 10.1089/aid. 0184, 2015
“IFN-α-induced downregulation of miR-221 in dendritic cells: implications for HCV pathogenesis and treatment"
Sehgal M, Zeremski M, Talal AH, Ginwala R, Elrod E, Grakoui A, Li QG, Philip R, Khan ZK and P Jain
Journal of Interferon and Cytokine Research, 2015
“Apigenin, a natural flavonoid, attenuates EAE severity through the modulation of dendritic cell and other immune cell functions"
Ginwala R, McTish E, Raman C, Singh N, Nagarkatti M, Sagar D, Jain P and ZK Khan
Journal of Neuroimmune Pharmacology, 2015
“Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB”
Jain P*, Lavorgna A, Sehgal M, Gao L, Ginwala R, Sagar D, Harhaj EW and ZK Khan* (*Corresponding authors)
Retrovirology, Feb 27; 12:23.doi: 10.1186/s12977-015-0140-1, 2015
“Host genetic factors and dendritic cell responses associated with the outcome of interferon/ribavirin treatment in HIV-1/HCV co-infected individuals"
Sehgal M, Zeremski M, Talal AH, Khan ZK, Capocasale R, Philip R and P Jain
Journal of Clinical and Cellular Immunology, Oct 31; 5. pii: 1000271, 2014
“In vivo immunogenicity of tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine"
Sagar D, Masih S, Schell T, Jacobson S, Comber JD, Philip R, Wigdahl B, Jain P and Khan ZK
Vaccine, 32(26): 3274-84, 2014
“Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaque"
Hollenbach R, Sagar D, Khan ZK, Callen S, Yao H, Shirazi J, Buch S and P Jain
Journal of Neurovirology, 20(2): 175-83, 2014
“Targeting the C-type lectins-mediated host-pathogen interactions with dextran"
Pustylnikov S, Sagar D, Jain P, and ZK Khan
Journal of Pharmacy and Pharmaceutical Sciences, 17(3): 371-92, 2014
PubMed [journal] PMID: 25224349
“Epigenetics, drugs of abuse, and the retroviral promoter"
Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, Khan ZK and P Jain
Journal of Neuroimmune Pharmacology, 8(5): 1181-96, 2013
“Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of humanT-cell leukemia virus type 1"
Manuel SL, Sehgal M,Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P
Journal of Clinical Immunology, 33(7): 1223-39, 2013
“An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1"
Manuel SL, Sehgal M, Khan ZK, Goedert JJ, Betts MR and P Jain
AIDS Research and Human Retroviruses, 29(9): 1273-85, 2013
“Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?”
Sehgal M, Khan ZK, Talal AH and P Jain
Virology Research and Treatment, 4:1-25, 2013
“Transgenic Animals and Their Applications”
“Masih SJ, P. Jain and ZK Khan
In: Animal Biotechnology: Models in Discovery and Translation, Edit Book: Elsevier
Science Publications, USA, pp 407-423, 2013
“Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation"
Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper M and P Jain
Journal of Neuroinflammation, 9: 245,2012
“Mechanisms of dendritic cell trafficking across the blood-brain barrier"
Sagar D, Foss C, El Baz R, Pomper MG, Khan ZK and P Jain
Journal of Neuroimmune Pharmacology, 7(1): 74-94, 2012
“Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective”
Aliya N, Rahman S, Khan ZK and P Jain
Leukemia Research and Treatment, 2012:984754, doi: 10.1155/2012/984754, 2012
“HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter”
Rahman S, Quann K, Pandya D, Singh S, Khan ZK and P Jain
PloS One, 7(4): e 34490, doi: 10.1371/journal.pone.0034490, 2012
“A novel high-throughput screening assay to identify inhibitors of HIV-1 gp120 protein interaction with DC-SIGN"
Tran TH, El Baz R, Cuconati A, Arthos J, Jain P and ZK Khan
Journal of Antivirals and Antiretrovirals, 3: 49-54, 2011
“The tug-of-war between dendritic cells and human chronic viruses"
Rahman S, Khan ZK and P Jain
International Reviews of Immunology, 30(5-6): 341-65, 2011
“Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection"
Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F and P Jain
Journal of Immunology, 186(1): 390-402, 2011
“Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR"
Liu Y, Nonnemacher MR, Stauff DL, Li L, Banerjee A, Irish B, Kilareski E, Rajagopalan
N, Suchitra JB, Khan ZK, Ranga U and B. Wigdahl
Biomedicine and Pharmacotherapy, 64(10): 672-80, 2010
“Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell Leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice"
Rahman S, Manuel SL, Khan ZK, Wigdahl B, Acheampong E, Tangy F and P Jain
Journal of Immunology, 184(10): 5553-61, 2010
“DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells"
Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K and B Wigdahl
Journal of Virology, 83(21): 10908-21, 2009
“Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease"
Manuel SL, Schell TD, Acheampong E, Rahman S, Khan ZK and P Jain
Journal of Leukocyte Biology, 86(5): 1205-16, 2009
“Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review"
Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, Rajagopalan N, Suchitra JB, Mostoller K, Wigdahl B
American Journal of Infectious Diseases, 5(3): 231-258, 2009
“Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease"
Lepoutre V, Jain P, Quann K, Wigdahl B, Khan ZK
Frontiers in Bioscience, 14:1152-68, 2009
“Mortality among HIV-infected patients in resource limited settings: a case controlled analysis of inpatients at a community care center”.
Rajagopalan N, Suchitra JB, Shet A, Khan ZK, Martin-Garcia J, Nonnemacher MR,
Jacobson JM and B Wigdahl
American Journal of Infectious Diseases, 5(3): 219-224, 2009
“Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein"
Jain P, Mostoller K, Flaig KE, Ahuja J, Lepoutre V, Alefantis T, Khan ZK, and B Wigdahl
The Journal of Biological Chemistry, 282(47): 34581-93, 2007